Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...

Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices, with firms such as Abbott Diabetes Care and Bayer having a ...

Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

Janney Montgomery Scott LLC lessened its stake in Sanofi (NASDAQ:SNY – Free Report) by 0.3% in the third quarter, according ...

The company provides specialty care, such as DUPIXENT ... medicines for diabetes and cardiovascular diseases; and established ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with ...

taking into account its recent acquisition from Sanofi (SASY.PA), opens new tab of the global rights to Enjaymo, a rare immune disorder drug. On the M&A front, he said Recordati continued to look for ...

Therefore, Sanofi's partnership with Sudair Pharma aims to address this gap and increase access to effective care for people with diabetes through insulin localization. “We take immense pride in being ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so familiar routine of online meetings, calls, and ...

Sanofi has moved a step closer to getting its new diabetes therapy Zynquista approved in Europe, with a positive opinion from the Committee for Medicinal Products ... to get the care they need ...